NCT03466086 is a Phase 4 clinical trial of Test Eye Drops in Visual Acuity, sponsored by Johnson & Johnson Vision Care, Inc..

Who is sponsoring NCT03466086?

NCT03466086 is sponsored by Johnson & Johnson Vision Care, Inc..

What drugs are being tested in NCT03466086?

Interventions in NCT03466086: Test Eye Drops, Control Eye Drops.

What condition does NCT03466086 study?

NCT03466086 studies Visual Acuity.

Is NCT03466086 still recruiting?

NCT03466086 is currently completed. Last updated 28 June 2019.

Are results published for NCT03466086?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-06-28 · How we verify

NCT03466086

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing Patients

Completed Phase 4 Results posted Last updated 28 June 2019

What this trial tests

Phase 4 trial testing Test Eye Drops in Visual Acuity in 57 participants. Completed in 16 May 2018.

Timeline

9 February 2018

Primary endpoint
16 May 2018

16 May 2018

Quick facts

Lead sponsor	Johnson & Johnson Vision Care, Inc.
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	57
Start date	9 February 2018
Primary completion	16 May 2018
Estimated completion	16 May 2018
Sites	1 location across United Kingdom

Drugs / interventions tested

Test Eye Drops
Control Eye Drops

Conditions studied

Visual Acuity — all drugs for Visual Acuity →

Sponsor

Johnson & Johnson Vision Care, Inc. — full company profile →

Who can join

Adults 18 to 69, any sex, with Visual Acuity. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Ocular Comfort Primary · 1-Week Follow-up

Ocular comfort was measured using the visual analogue scale of 0 to 100. Where 0 is extremely uncomfortable and 100 is extremely comfortable.

Group	Value	95% CI
Test	81.96	± 12.407
Control	82.49	± 15.238

Subjective Dryness Rating Secondary · 1-Week Follow-up

Subjective dryness was assessed using Ocular Surface Disease Index (OSDI©) instrument. Dryness is evaluated on a scale of 0 to 100, where higher scores indicate more symptoms of dryness

Group	Value	95% CI
Test	25.68	± 10.162
Control	24.69	± 10.609

Sponsor's own description

This clinical study is a randomized, double-masked, cross-over, bilateral, 2 treatment x 2 period, dispensing 4-visit study with a 7-9 day washout period in between visits 2 and 3. The study will last approximately 3 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Visual Acuity

Currently open trials in the same condition.

NCT07443215 — Evaluation of Effect of Scatter on Visual Performance · NA · recruiting
NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath · NA · active not recruiting
NCT07085533 — Natural History Study of Inherited Retinal Diseases · recruiting
NCT07135180 — Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups · NA · active not recruiting
NCT04632901 — A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA) · active not recruiting

Other Johnson & Johnson Vision Care, Inc. trials

Trials by the same sponsor.

NCT07443215 — Evaluation of Effect of Scatter on Visual Performance · NA · recruiting
NCT07174596 — Evaluation of Approved Contact Lenses · NA · completed
NCT07076160 — Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses · NA · completed
NCT06967129 — Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process · NA · completed
NCT06864858 — Clinical Evaluation of Two Cosmetic Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03466086 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Vision Care, Inc.
Last refreshed: 28 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03466086.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing